Journey Medical (DERM) Non Operating Interest Expenses (2020 - 2026)

Journey Medical (DERM) has reported Non Operating Interest Expenses for 7 consecutive years, with $906000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses fell 3.31% year-over-year to $906000.0; the trailing twelve-month figure through Jun 2026 stood at $3.7 million (up 7.35% YoY), and the FY2025 full-year result was $3.7 million, up 36.96% from the prior year.
• Non Operating Interest Expenses rose to $906000.0 in Q2 2026 per DERM's latest filing, from $892000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $937000.0 in Q2 2025 and bottomed at $24000.0 in Q4 2023.
• Historically, Non Operating Interest Expenses has averaged $661833.3 across 5 years, with a median of $703000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses sank 96.11% in 2023, then surged 3362.5% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $617000.0 in 2022, then tumbled by 96.11% to $24000.0 in 2023, then soared by 3362.5% to $831000.0 in 2024, then climbed by 12.27% to $933000.0 in 2025, then decreased by 2.89% to $906000.0 in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $906000.0, $892000.0, and $933000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.